A detailed history of Tower Research Capital LLC (Trc) transactions in Champions Oncology, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 2,553 shares of CSBR stock, worth $11,539. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,553
Holding current value
$11,539
% of portfolio
0.0%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$3.95 - $5.14 $10,084 - $13,122
2,553 New
2,553 $12,000
Q3 2023

Nov 14, 2023

BUY
$5.2 - $7.32 $78 - $109
15 Added 250.0%
21 $0
Q2 2023

Aug 14, 2023

SELL
$4.11 - $6.81 $10,895 - $18,053
-2,651 Reduced 99.77%
6 $0
Q1 2023

May 09, 2023

BUY
$4.0 - $4.67 $2,792 - $3,259
698 Added 35.63%
2,657 $10,000
Q4 2022

Feb 10, 2023

BUY
$3.75 - $7.69 $7,278 - $14,926
1,941 Added 10783.33%
1,959 $9,000
Q3 2022

Nov 10, 2022

SELL
$7.21 - $9.47 $108 - $142
-15 Reduced 45.45%
18 $0
Q2 2022

Aug 15, 2022

BUY
$6.81 - $8.31 $224 - $274
33 New
33 $0
Q4 2021

Feb 14, 2022

SELL
$7.76 - $10.23 $907 - $1,196
-117 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$9.11 - $10.96 $5,083 - $6,115
-558 Reduced 82.67%
117 $1,000
Q2 2021

Aug 16, 2021

SELL
$8.45 - $11.72 $13,215 - $18,330
-1,564 Reduced 69.85%
675 $7,000
Q1 2021

May 17, 2021

SELL
$10.61 - $13.75 $6,801 - $8,813
-641 Reduced 22.26%
2,239 $26,000
Q4 2020

Feb 16, 2021

SELL
$8.39 - $13.27 $33,249 - $52,589
-3,963 Reduced 57.91%
2,880 $31,000
Q3 2020

Nov 16, 2020

BUY
$7.05 - $10.2 $10,955 - $15,850
1,554 Added 29.38%
6,843 $63,000
Q2 2020

Aug 13, 2020

BUY
$6.65 - $9.84 $33,895 - $50,154
5,097 Added 2654.69%
5,289 $50,000
Q1 2020

May 15, 2020

SELL
$4.19 - $8.62 $6,976 - $14,352
-1,665 Reduced 89.66%
192 $1,000
Q4 2019

Feb 07, 2020

SELL
$5.12 - $8.33 $2,908 - $4,731
-568 Reduced 23.42%
1,857 $15,000
Q3 2019

Nov 05, 2019

BUY
$5.4 - $8.99 $4,924 - $8,198
912 Added 60.28%
2,425 $14,000
Q2 2019

Aug 13, 2019

BUY
$7.51 - $10.12 $8,268 - $11,142
1,101 Added 267.23%
1,513 $12,000
Q1 2019

May 14, 2019

SELL
$7.89 - $12.23 $4,986 - $7,729
-632 Reduced 60.54%
412 $4,000
Q4 2018

Feb 14, 2019

BUY
$7.29 - $15.27 $7,610 - $15,941
1,044 New
1,044 $8,000
Q3 2018

Nov 13, 2018

SELL
$5.82 - $17.47 $10,470 - $31,428
-1,799 Closed
0 $0
Q2 2018

Aug 15, 2018

BUY
$3.6 - $7.27 $165 - $334
46 Added 2.62%
1,799 $11,000
Q1 2018

May 15, 2018

SELL
$3.39 - $4.39 $2,644 - $3,424
-780 Reduced 30.79%
1,753 $6,000
Q4 2017

Feb 09, 2018

BUY
$3.17 - $4.16 $8,029 - $10,537
2,533
2,533 $10,000

Others Institutions Holding CSBR

About CHAMPIONS ONCOLOGY, INC.


  • Ticker CSBR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 13,522,400
  • Market Cap $61.1M
  • Description
  • Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Techn...
More about CSBR
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.